Stratec SE (ETR:SBS) was down 0.7% during trading on Friday . The stock traded as low as €87.60 ($98.43) and last traded at €88.40 ($99.33), approximately 8,227 shares changed hands during mid-day trading. An increase of 32% from the average daily volume of 6,253 shares. The stock had previously closed at €89.00 ($100.00).
A number of research firms have commented on SBS. Warburg Research set a €69.00 ($77.53) target price on shares of Stratec and gave the stock a “neutral” rating in a research report on Friday, May 15th. Deutsche Bank set a €97.00 ($108.99) price objective on shares of Stratec and gave the stock a “buy” rating in a research note on Thursday, May 21st. Kepler Capital Markets set a €95.00 ($106.74) price target on shares of Stratec and gave the company a “buy” rating in a report on Tuesday, May 5th. Finally, Berenberg Bank set a €80.00 ($89.89) price target on shares of Stratec and gave the stock a “buy” rating in a report on Thursday, March 26th.
The stock’s 50 day simple moving average is €81.03 and its 200-day simple moving average is €73.08. The company has a market capitalization of $925.95 million and a PE ratio of 62.65. The company has a debt-to-equity ratio of 66.24, a current ratio of 3.67 and a quick ratio of 2.25.
Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers.
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.